| Project Scope |
|---|
This project team will create a users guide or White Paper with recommendations |
...
for analysis and displays for Laboratory Data, with a focus on Phase 2-4 clinical trials and integrated submission documents. There have been 2 previous White Papers on this topic (1 for central tendency in 2013 and 1 for |
...
Outliers/ |
...
Shifts in 2015). This paper will combine two method types and update recommendations given the advancement in interactive options. |
| Project |
|---|
...
Wei Wang - wang_wei_v@lilly.com
| Leads | |
|---|---|
| Charles Beasley, Beasley Pharmaceutical and Biotechnology Consulting | charlesmbeasleyjr@msn.com |
| Christopher Smith, FDA | christopher.smith2@fda.hhs.gov |
| Nicola Newton, PHUSE Project Assistant |
| ||||||
|---|---|---|---|---|---|---|
Project Closed. |
Objectives & Deliverables | Timelines |
|---|---|
Align on next steps | Q2 2023 |